67 related articles for article (PubMed ID: 2993000)
1. Increase in nigral type II benzodiazepine recognition sites following striatonigral denervation.
Porceddu ML; Corda MG; Sanna E; Biggio G
Eur J Pharmacol; 1985 Jun; 112(2):265-7. PubMed ID: 2993000
[TBL] [Abstract][Full Text] [Related]
2. Striato-nigral denervation increases type II benzodiazepine receptors in the substantia nigra of the rat.
Corda MG; Concas A; Porceddu ML; Sanna E; Biggio G
Neuropharmacology; 1986 Jan; 25(1):59-62. PubMed ID: 3005905
[TBL] [Abstract][Full Text] [Related]
3. Functional changes in rat nigral GABA(A) receptors induced by degeneration of the striatonigral GABAergic pathway: an electrophysiological study of receptors incorporated into Xenopus oocytes.
Sanna E; Motzo C; Usala M; Pau D; Cagetti E; Biggio G
J Neurochem; 1998 Jun; 70(6):2539-44. PubMed ID: 9603220
[TBL] [Abstract][Full Text] [Related]
4. Differential localization of type I and type II benzodiazepine binding sites in substantia nigra.
Lo MM; Niehoff DL; Kuhar MJ; Snyder SH
Nature; 1983 Nov 3-9; 306(5938):57-60. PubMed ID: 6314146
[TBL] [Abstract][Full Text] [Related]
5. Denervation supersensitivity for benzodiazepine receptors in the rat substantia nigra.
Biggio G; Corda MG; Concas A; Gessa GL
Brain Res; 1981 Sep; 220(2):344-9. PubMed ID: 6269689
[TBL] [Abstract][Full Text] [Related]
6. Binding of girisopam (a 2,3-benzodiazepine derivative) to the substantia nigra is prevented by lesioning of the striatonigral pathway.
Palkovits M; Lovas G; Horváth E
Neuroscience; 1998 Apr; 83(3):799-806. PubMed ID: 9483563
[TBL] [Abstract][Full Text] [Related]
7. In vivo release of newly synthesized [3H]GABA in the substantia nigra of the rat: relative contribution of GABA striato-pallido-nigral afferents and nigral GABA neurons.
Lantin le Boulch N; Truong-Ngoc NA; Gauchy C; Besson MJ
Brain Res; 1991 Sep; 559(2):200-10. PubMed ID: 1794098
[TBL] [Abstract][Full Text] [Related]
8. Characterization of benzodiazepine receptor changes in substantia nigra, globus pallidus and entopeduncular nucleus after striatal lesions.
Pan HS; Penney JB; Young AB
J Pharmacol Exp Ther; 1984 Sep; 230(3):768-75. PubMed ID: 6147405
[TBL] [Abstract][Full Text] [Related]
9. Neurotransmitter receptor localizations: brain lesion induced alterations in benzodiazepine, GABA, beta-adrenergic and histamine H1-receptor binding.
Chang RS; Tran VT; Snyder SH
Brain Res; 1980 May; 190(1):95-110. PubMed ID: 6103733
[TBL] [Abstract][Full Text] [Related]
10. GABA and benzodiazepine receptors in the cat motor thalamus after lesioning of nigro- and pallidothalamic pathways.
Kultas-Ilinsky K; Hughes B; Fogarty JD; Ilinsky IA
Brain Res; 1990 Mar; 511(2):197-208. PubMed ID: 2159356
[TBL] [Abstract][Full Text] [Related]
11. Evidence suggesting denervation supersensitivity of nigral GABA receptors following destruction of the striatonigral GABA pathway in the rat [proceedings].
Cross AJ; Waddington JL
J Physiol; 1978 Sep; 282():30P-31P. PubMed ID: 214545
[No Abstract] [Full Text] [Related]
12. The localization of receptor binding sites in the substantia nigra and striatum of the rat.
Reisine TD; Nagy JI; Beaumont K; Fibiger HC; Yamamura HI
Brain Res; 1979 Nov; 177(2):241-52. PubMed ID: 227532
[TBL] [Abstract][Full Text] [Related]
13. Dramatic increase in nigral t-[35S]butylbicyclophosphorothionate binding sites elicited by the degeneration of the striato-nigral GABAergic pathway: reversal by diazepam.
Sanna E; Serra M; Pepitoni S; Biggio G
Brain Res; 1989 Oct; 501(1):144-9. PubMed ID: 2553212
[TBL] [Abstract][Full Text] [Related]
14. Autoradiographic differentiation of multiple benzodiazepine receptors by detergent solubilization and pharmacologic specificity.
Lo MM; Niehoff DL; Kuhar MJ; Snyder SH
Neurosci Lett; 1983 Aug; 39(1):37-44. PubMed ID: 6314190
[TBL] [Abstract][Full Text] [Related]
15. In vivo [3H]flunitrazepam binding: imaging of receptor regulation.
Ciliax BJ; Penney JB; Young AB
J Pharmacol Exp Ther; 1986 Aug; 238(2):749-57. PubMed ID: 3016249
[TBL] [Abstract][Full Text] [Related]
16. Characterization of benzodiazepine binding sites after short-wave photo-affinity labeling with flunitrazepam.
Herblin WF
Life Sci; 1986 Feb; 38(6):507-14. PubMed ID: 3003483
[TBL] [Abstract][Full Text] [Related]
17. The striatonigral GABA pathway: functional and neurochemical characteristics in rats with unilateral striatal kainic acid lesions.
Waddington JL; Cross AJ
Eur J Pharmacol; 1980 Oct; 67(1):27-32. PubMed ID: 6252027
[TBL] [Abstract][Full Text] [Related]
18. Cortical ablation fails to influence striatal dopamine target cell supersensitivity induced by nigrostriatal denervation in the rat.
Paturle L; Fage D; Fourrier O; Vernier P; Feuerstein C; Demenge P; Scatton B
Brain Res; 1987 Feb; 402(2):383-6. PubMed ID: 3828803
[TBL] [Abstract][Full Text] [Related]
19. Gamma-aminobutyric acidA and benzodiazepine receptor alterations in the rat brain after unilateral 6-hydroxydopamine lesions of the medial forebrain bundle.
Araki T; Matsubara M; Fujihara K; Kato H; Imai Y; Itoyama Y
Neurol Res; 2002 Jan; 24(1):107-12. PubMed ID: 11783749
[TBL] [Abstract][Full Text] [Related]
20. Comparison of content with synthesis, uptake and breakdown of GABA in substantia nigra of unoperated, hemitransected and kainate-treated rats.
Starr M; Kilpatrick I
Life Sci; 1981 Nov; 29(22):2281-7. PubMed ID: 7321760
[No Abstract] [Full Text] [Related]
[Next] [New Search]
